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Abstract Multilevel anatomic obstruction is often pres-
ent in snoring and obstructive sleep apnoea (OSA). As the
nose is the ﬁrst anatomical boundary of the upper airway,
nasal obstruction may contribute to sleep-disordered
breathing (SDB). A number of pathophysiological mecha-
nisms can potentially explain the role of nasal pathology in
SDB. These include the Starling resistor model, the
unstable oral airway, the nasal ventilatory reﬂex and the
role of nitric oxide (NO). Clinically, a number of case–
control studies have shown that nasal obstruction is asso-
ciated with snoring and mild SDB. However, there is not a
linear correlation between the degree of nasal obstruction
and the severity of SDB, while nasal obstruction is not the
main contributing factor in the majority of patients with
moderate to severe OSA. Randomised controlled studies
have shown that in patients with allergic rhinitis or non-
allergic rhinitis and sleep disturbance, nasal steroids could
improve the subjective quality of sleep, and may be useful
for patients with mild OSA, however, they are not by
themselves an adequate treatment for most OSA patients.
Similarly, nasal surgery may improve quality of life and
snoring in a subgroup of patients with mild SDB and septal
deviation, but it is not an effective treatment for OSA as
such. On the other hand, in patients who do not tolerate
continuous positive airway pressure (CPAP) well, if upper
airway evaluation demonstrates an obstructive nasal pas-
sage, nasal airway surgery can improve CPAP compliance
and adherence.
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Introduction
Hippocrates in ‘‘de Morbis Popularibis’’ (Peqi 9
Epidglix 9m) noted that nasal polyps were associated with
restless sleep [1]. Indeed, most people have experienced
sleeping difﬁculty during episodes of virally induced nasal
congestion. Hence, a link between nasal breathing and
sleep as well as improvement of sleep quality following
relief of nasal obstruction would seem intuitive. However,
the literature is not conclusive in that respect despite the
interest in the area, as demonstrated by the number of
relevant articles published. Nevertheless, our understand-
ing of nasal and sleep physiology and particularly of the
importance of nasal and oral breathing as relating to sleep
apnoeas and total airway resistance has signiﬁcantly pro-
gressed over the last decade, while recent double-blind
randomised controlled trials evaluating treatment outcomes
objectively and the use of quality of life (QoL) outcome
instruments have further added to our knowledge.
Sleep apnoea is usually deﬁned as cessation of air ﬂow
into the lungs which lasts for more than 10 s. The severity
of sleep apnoea is deﬁned primarily by the apnoea/hyp-
opnoea index (AHI)—the number of apnoeas (cessation of
airﬂow for more than 10 s) and hypopneas (variable deﬁ-
nitions, usually signiﬁcant decrease in airﬂow) per hour [2].
Sleep-related breathing disorder (SRBD) is essentially a
disease continuum ranging from simple or primary snoring
at one end to obstructive sleep apnoea (OSA) at the other
[3]. Upper airway resistance syndrome (UARS) occupies
an intermediate position in this spectrum. The prevalence
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range of 25–50% [4], whereas signiﬁcant sleep-disordered
breathing affects up to 8% of males and 3% of females [5]
(as shown in the recent prospective Sleep Heart population
study in 6,441 subjects). Dynamic MRI imaging, acoustic
analysis, sedation endoscopy and pharyngeal luminal
pressure recordings have established the fact that both
snoring and OSA are multilevel phenomena [6–10]
whereby turbulent airﬂow is associated with obstruction in
the naso, oro and hypopharynx in differing proportions in
individual patients. As the nose constitutes the ﬁrst port of
entry of inspired air under normal conditions, nasal
pathology has a signiﬁcant impact on air ﬂow and hence,
potentially contribute to SRBD [11, 12].
Effects of nasal obstruction on breathing during sleep
The nose accounts for more than 50% of the total resistance
of the upper airway and nasal breathing serves important
physiological functions, including humidiﬁcation, heating
and ﬁltration [13]. Physiological mechanisms that explain
the relationship between nasal airﬂow and breathing during
sleep include the Starling resistor model, the unstable oral
airway proposition, the nasal ventilatory reﬂex and the role
of nitric oxide (NO) (Table 1).
The Starling resistor model [14, 15] (Fig. 1) views the
upper airway as a hollow tube, with a partial obstruction at
the inlet (corresponding to the nose) and a collapsible
segment downstream, corresponding to the oropharynx.
This model predicts that a further obstruction upstream
(nose) will generate a suction force (negative intraluminal
pressure) downstream (oropharynx) resulting, in predis-
posed individuals, in oropharyngeal collapse. This effect is
exacerbated at the supine position, when nasal resistance
tends to increase both actively due to postural reﬂex
mechanisms as well as passively as a result of the reduced
hydrostatic pressure on nasal venous circulation [16].
One can argue that this model fails to take into account a
major feature of normal breathing, namely oral breathing
bypass, the option of mouth breathing when nasal resis-
tance exceeds a certain level. However, this switch (from
nasal breathing to oral breathing) is physiologically dis-
advantageous and results in unstable oral breathing. During
sleep, upper airway resistance is lower in subjects breath-
ing through the nose than that through the mouth, unlike
awake state, during which upper airway resistance is the
same in nasal or oral breathing [17]. Hence, the fraction of
oral breathing normally decreases during sleep from 7.6 to
4.3% [18]. When the nasal airway is almost completely
obstructed, a switch from nose to mouth breathing occurs,
but at a high physiological cost. Mouth breathing is asso-
ciated with up to 2.5 times higher total resistance [17] and
with narrowing of the pharyngeal lumen, decrease in the
retroglossal diameter as a result of further posterior
retraction of the tongue and increase in the oscillation of
the soft palate and redundant pharyngeal tissue [19], all
factors leading to SRDB.
A third factor is nasal-ventilator reﬂex. Experimental
application of local anaesthetics to the nasal mucosa of
healthy volunteers leads to a signiﬁcant increase of both
central and obstructive apnoeic episodes, of the same
magnitude to those reported with complete nasal obstruc-
tion [20]. Similar results from other experiments [21]
conﬁrmed that the activation of nasal receptors during
nasal breathing has a direct positive effect on spontaneous
ventilation resulting in higher resting breathing frequency
and minute ventilation. Bypassing the nasal airway can
lead to reduced nasal receptor activation, deactivation of
the nasal-ventilatory reﬂex and reduced spontaneous ven-
tilation which, in a subset of susceptible individuals can
be associated with exacerbating or unmasking previously
Table 1 Pathophysiology of nasal function in the pathogenesis of OSA
a. Starling resistor model Elevated nasal resistance upstream results in increased negative pressure (suction force) in oropharyngeal
airway downstream
b. Unstable oral breathing Signiﬁcantly increased nasal airway resistance results in compensatory increase of oral breathing fraction
and switching to breathing through an unstable oral airway, resulting in increased total airway resistance
c. Nasal-ventilatory reﬂex Decreased nasal airﬂow results in decreased activation of nasal receptors with subsequent inhibitory action
on muscle tone, breathing frequency and minute lung ventilation
d. Nitric oxide Decreased nasal ﬂow results to reduced lung NO with resultant potential perfusion ventilation mismatch
as well as various effects on oropharyngeal musculature and arousals
Fig. 1 The Starling resistor model of upper airway collapsibility. The
upper airway behaves like a Starling resistor in that obstruction at the
inlet (i.e. the nasal airway) produces collapsing forces that are
manifest downstream in the collapsible segment, the pharynx
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duration of apnoeic episodes [23].
Finally NO is thought to play a role in maintaining
upper airway patency by acting as an aerotransmitter
between the nose, pharyngeal musculature and the lung
[24]. NO is produced in signiﬁcant amounts in the nose and
sinuses and has been shown to be (and used clinically as) a
potent lung vasodilator, reducing perfusion-ventilation
mismatch and improving overall blood oxygenation [25].
As the total amount of inspired NO varies accordingly to
nasal ﬂow [26], it seems logical that a decrease of nasal
ventilation would result in reduced NO delivery to the
lungs and a reduced oxygen exchange capability. However,
NO has also a role in the maintenance of muscle tone and
the regulation of neuromuscular pathways in the pharyn-
geal musculature as well as spontaneous breathing and
sleep regulation, so, overall, its role in the nasal regulation
of OSA although probably quite signiﬁcant, is still not
completely understood [27].
Clinical and experimental evidence of correlation
between nasal pathology and SDB
Several lines of evidence suggest that experimental
reduction of nasal patency and ﬂow has a signiﬁcant effect
on breathing during sleep. In one study, intranasal appli-
cation of petroleum jelly gauzes in healthy volunteers-
induced obstructive apnoeic episodes and resulted in sig-
niﬁcant increases in AHI, producing frank OSA in one
subject [28]. In another study, artiﬁcially induced complete
or partial nasal obstruction resulted in signiﬁcant alteration
of sleep pattern, with increased micro arousals and total
number of apnoeas [29]. In a clinical setting, a number of
studies have shown that the application of nasal packs
during the management of epistaxis results in signiﬁcantly
worse quality of sleep with multiple apnoeas and desatu-
ration episodes [12, 30–32]. Hence, it is probably safe to
conclude that artiﬁcially induced partial or complete nasal
obstruction results in increased sleep apnoeas.
Nasal obstruction experienced by patients could be due
to structural abnormalities (e.g. deviated nasal septum,
enlarged turbinates and nasal valve collapse), inﬂammatory
mucosal disease (rhinitis, chronic rhinosinusitis with or
without nasal polyps) or more rarely due to neuromuscular
problems. Numerous observational studies have demon-
strated that nasal congestion is associated with snoring and
daytime sleepiness: Wisconsin Sleep Study, a prospective
population study of 1,032 healthy volunteers, showed a
threefold increased incidence of snoring and day time
sleepiness in volunteers with self-reported nocturnal
nasal congestion [33], while a study of 37 patients
assessed with polysomnography and rhinomanometry
showed a correlation between nasal resistance in the supine
position and habitual snoring [34]. On the other hand,
Lofaso et al. [35] in a prospective study showed that nasal
obstruction as documented by posterior rhinomanometry in
the awake state is an independent risk factor for OSA,
albeit accounting for only 2.3% of the total AHI variance.
These results have been contradicted by some other studies
including the study by Miljeteig et al. [36], who divided
683 patients referred for sleep polysomnography in three
groups, on the basis of their nasal resistance. He subse-
quently failed to ﬁnd any differences in apnoea and snoring
indices between the three groups [36]. However, the study
assessed awake nasal resistance in the erect position, while,
as the authors noted themselves, it seems more likely that
sleep disturbances correlate with supine nasal obstruction
during sleep. The same authors performed a few years later
a similar study measuring supine nasal resistance and again
failed to ﬁnd any correlation with Sleep Disturbance indi-
ces, however, their study did not include patients with
signiﬁcant nasal obstruction, while all the measurements
were done in non-physiologic conditions, with the subjects
having their mouths taped (!) throughout the night to pre-
vent oral breathing [37].
Epidemiological studies [38] have shown that allergic
rhinitis (AR) affects 9–42% of the population. The mech-
anism by which allergic rhinitis causes poor sleep quality
and daytime fatigue is not entirely clear but it is thought
that multiple factors are involved. Apart from nasal
obstruction, various inﬂammatory mediators such as IFN-g,
TNF-a, IL-1b, IL-4, and IL-10 [39, 40], postural changes
and some therapeutic agents such as antihistamines may
also have a direct effect on sleep regulation. In patients
with AR a direct association between nasal resistance and
SRDB severity has been found [41] as well as between
nasal obstruction and subjective quality of sleep and day-
time sleepiness [42]. A recent study found that both AR
and non-allergic rhinitis (NAR) are associated with
impaired sleep quality, with up to 83% of NAR patients
having sleep complaints [43].
In a recent overview McNicholas [44] tried to synthesise
these apparently conﬂicting results, pointing out that
reversible nasal obstruction maybe more closely associated
with SRDB than permanent nasal obstruction, noting that
studies assessing patients with temporal obstruction
(including iatrogenic and allergic rhinitis) tended to show a
more consistent association with SDB than studies
assessing patients with structural abnormalities such as
deviated nasal septum.
In conclusion, it appears that nasal obstruction, espe-
cially reversible, either artiﬁcial or disease-induced, is
associated with snoring and mild SDB. However, a direct
correlation between the degree of nasal obstruction and the
severity of SDB has not been found and certainly, nasal
Eur Arch Otorhinolaryngol (2011) 268:1365–1373 1367
123obstruction does not appear to be the main contributing
factor in the majority of patients with moderate to severe
OSA.
Management options
Introduction—problems with research
Nasal pathology associated with nasal obstruction can be
treated medically (nasal steroids, antihistamines, decon-
gestants, leukotriene antagonists and nasal dilators) or
surgically. Although a number of clinical trials have
assessed the effectiveness of the above, they lacked uni-
formity and only a handful had objective outcome mea-
sures. Many of the studies were non-randomised, lacked a
control group, had small number of patients and short
follow-up periods.
Another problem in many of the studies assessing the
efﬁcacy of these treatments, was the lack of clear inclusion
criteria. In many studies that was just self-reported nasal
obstruction, while in others it was physician’s assessment.
On the other hand, the use of objective criteria for nasal
obstruction (such as rhinomanometry or acoustic rhinom-
etry) must take into account the unreliable correlation
between what these studies measure and what the patient
experiences as nasal obstruction. Finally, the results of
studies on the effectiveness of medication on nasal
pathology (such as allergic rhinitis) assess the effect of
treating the underlying disease and not the effect of treating
nasal obstruction as such.
Medical treatment
In patients with chronic rhinitis the main cause of high
nasal resistance is excessive swelling and engorgement of
nasal mucosa. In terms of conservative treatment this could
be overcome by topical steroids, sympathomimetic
decongestants, or (in the case of AR), by antihistamines
and leukotriene antagonists.
Nasal steroids
Randomised trials
There are four double-blind randomised controlled studies
assessing the efﬁcacy of nasal steroids on sleep quality in
patients with allergic rhinitis [45–48] (Table 2). Only one
of these, however, had objective outcome measures and
included OSA patients [47], while the other three studies
[45, 46, 48] included patients with self-described poor
quality of sleep. These three studies were performed using
the same methodology, selection criteria and outcomes
but with different nasal steroids. Their results have been
pooled and presented together by the authors in 2005
[49]. In summary, they showed that patients with Skin
Prick Test proven perennial allergic rhinitis had subjective
improvement in their quality of sleep as well as reduced
daytime sleepiness following treatment with nasal ste-
roids, and this improvement correlated with improvement
of nasal patency. In the one [46] where sleep studies were
performed they showed no signiﬁcant change in AHI or
any other objectively measured sleep parameter. The
fourth trial by Kiely et al. [47] was performed in both
NAR and AR patients and also showed improvement in
subjective sleep quality in non-OSA patients but not in
patients with frank sleep apnoea. Rather contradictorily, it
showed a slight reduction of the AHI (by a mean of 6.5
points, from a median of 20 down to 13 episodes per
hour), however, most patients continued to have signiﬁ-
cant OSA.
In conclusion, in patients with AR or NAR and sleep
disturbance, nasal steroids improve the subjective quality
of sleep, however, although they maybe be useful as an
adjunct for patients with mild OSA, they are an inadequate
treatment for most OSA patients.
Decongestants
Randomised controlled trials
Three RCTs have been performed on the use of nasal
decongestants (oxymetazoline) in OSA: In the ﬁrst of
these studies [50] the decongestant was combined with an
internal nasal valve dilator, in the second one with an
external dilator (Breath Right
TM)[ 51] while a more
recent study assessed the effect of decongestant alone
[52]. The characteristics and results of the studies are
also presented in Table 2. Two of the three RCTs
showed no change in AHI and sleep architecture, while
the study by McLean showed a modest decrease in AHI
of limited clinical signiﬁcance but no improvement in
sleep quality or daytime somnolence. On the other hand,
the study by Clarenbach showed no improvement in
either subjective or objective indices of AHI. However, it
did show that at the time of maximal effect of oxymet-
azoline there was a signiﬁcant reduction in AHI, while
the study by Kerr demonstrated subjective improvements
in sleep quality.
Taken together, these results would show that although
nasal decongestants with or without nasal dilators are not
effective in the management of OSA (no improvement in
sleepiness or AHI). In any case, their use is limited for only
a few days, and hence, they could never be advocated for
the management of OSA.
1368 Eur Arch Otorhinolaryngol (2011) 268:1365–1373
123Leukotriene antagonists
A randomised double-blind crossover trial [53] assessing at
the effects of montelukast on 31 patients with persistent
allergic rhinitis and sleep disturbances found a signiﬁcant
effect of this leukotriene antagonist in reducing daytime
somnolence as measured by Epworth sleepiness scale.
However, none of the patients underwent polysomnogra-
phy and this result has not been replicated in any other
studies.
Nasal dilators
These devices increase the ability to breathe through the
nose by dilating the narrow nasal valve area. There are
two nasal dilators available: an externally applied
Breathe Right
 (CNS Inc; Bloomington, MN, USA) and
an internal device Nozovent
 (Prevancure AB, Sweden).
Four randomised non-blinded studies have been con-
ducted with these devices and an improvement in snor-
ing has been noted in three of them [54–57], but
improvement in objective sleep parameters in only one
study [54]. In this last study, however, at, [54] only
patients with mild OSA were recruited, while the
AHI decreased from 18 to 6.4 with no effect on
daytime sleepiness. In all other studies no effects on AHI
or daytime sleepiness was found. We feel that nasal
dilators are generally not recommended as a primary
treatment in patients with OSA but may be beneﬁcial in
simple snorers with nasal valve collapse. Their lack of
side effects and their price makes them in any case
worthy of trial in selected patients. If they help in
improving symptoms then it may be worthwhile for the
patient to be considered for deﬁnitive nasal valve
surgery.
Table 2 Randomised controlled studies assessing nasal pharmacological interventions for sleep disturbance
References Study design Patients Nasal
pathology
Intervention Objective outcomes Subjective
outcome
Notes
Kiely et al.
[47]
Double blind
crossover
RCT
10 simple
snorers (mean
AHI:3), 13
OSA patients
(mean AHI:
26.5)
PAR or SAR,
no septal
deviation
Fluticasone
100 mcg bd for
4 weeks
Median AHI reduced
in OSA patients
taking ﬂuticasone
from 30.3 to 23.0
(p\0.001)
Improvement
daytime
alertness for
non-apnoeic
patients, not
for OSA
patients
No patient with
OSA was cured
Craig et al.
[49]
Pooled results
from three
double
blind
randomised
crossover
trials
42 patients with
self-reported
daytime
somnolence
and impaired
sleep—OSA
patients
excluded
Subjective
nasal
obstruction
and SPT
proven
NAR
Nasal steroids od
(ﬂuticasone
200 mcg,
budesonide
128 mcg,
ﬂunisonide
200 mcg) for
3 weeks
Mesured only in
ﬂuticasone group:
no
polysomnographic
changes in AHI or
other sleep
parameters
Decreased sleep
problems (1.25
vs. 1.69;
p = 0.01),
decreased
sleepiness
(2.89 vs. 3.32;
p = 0.02)
Signiﬁcant
correlation
between changes
in nasal
congestion and
overall sleep
improvement
McLean
et al. [51]
Double blind
crossover
study
Ten OSA
patients
Clinician
assessed
nasal
obstruction
Topical
xylometazoline
(0.2 mg twice)
and external
dilator strip for
one night
AHI reduced by 12,
improved sleep
architecture
No improvement
in daytime
sleepiness
No correlation
between change
in nasal resitance
and AHI change.
Only one patient
had AHI\15
after treatment
Kerr et al.
[50]
Double blind
crossover
study
10 OSA patients Six had
clinician
and patient
assessed
nasal
obstruction
Topical
xylometazoline
before sleep
and internal
nasal dilator for
one night
No change in AHI,
slightly reduced
arousal episodes
Subjective
improvement
in sleep quality
Clarenbach
et al. [52]
Double blind
crossover
study
12 OSA patients Subjective
nasal
obstruction
Topical
xylometazoline
0.15 mg od
before sleep for
1 week
No change in AHI No improvement
in sleep quality
Signiﬁcant
decrease in AHI
at the time of
maximal
decongestion
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As primary treatment
Nasal surgery is usually conducted to alter structural
abnormalities present in primary snorers complaining of
nasal obstruction in addition to snoring. There is another
group of patients that may present to the rhinologist to
improve the efﬁcacy of their main treatment option of nasal
continuous positive airway pressure (CPAP). Surgical
procedures performed for SRBD include septoplasty/sep-
torhinoplasty, functional endoscopic sinus surgery, turbi-
nate reduction and nasal valve surgery.
Studies published in the 1980s and 1990s on effects of
septoplasty on snoring demonstrated reduction in snoring
by 50–75% [58–60]. In these studies, however, surgical
outcomes were measured subjectively using question-
naires or visual analogue scales. Series, assessing the
efﬁcacy of nasal surgery (septoplasty, turbinectomy, and
polypectomy) for OSA in a non-randomised study [61],
suggested that normal cephalometry values of posterior
airway space and mandibular plane to hyoid bone dis-
tances predicted surgical success. However, a more recent
study by Virkkula et al. [62] suggested that snoring is not
relieved by nasal surgery (septoplasty, septorhinoplasty
and turbinate reduction surgery) despite an improvement
in nasal resistance. This study conducted on forty Finnish
patients presenting with snoring looked at the outcomes
objectively using rhinomanometry, polysomnography and
snoring intensity index. They concluded that the snoring
time and intensity did not improve signiﬁcantly in their
patients, and that normal cephalometry did not predict a
good response. In contrast to this Finnish study, studies
from Korea [63] and Japan [64] assessing a different
ethnic group showed a signiﬁcant improvement in sleep
parameters. This may appear to be the case if p values are
examined (e.g. reduction of the respiratory disturbance
index (RDI) from 39 preoperatively to 29.4 postopera-
tively giving a p value of 0.0001 as reported by Kim et al.
[63]) but closer analysis of the study casts doubts on the
clinical signiﬁcance of this drop, if Sher’s criteria
(reduction of more than 50% in RDI or AHI or the actual
value to be \20) are applied [65].
Li et al. [66, 67] addressed recently the role of nasal
surgery in patients with snoring and OSA from two dif-
ferent perspectives. First, they looked at the efﬁcacy of
nasal surgery to relieve snoring [66] and tried to identify
predictive factors concluding that the tonsil size affected
the outcome of nasal surgery for snoring. Secondly, they
looked at the important issue of improvement in QoL after
nasal surgery alone for patients with OSA and nasal
obstruction [67]. In this study, they evaluated QoL using
generic and disease speciﬁc questionnaires. They utilised
the short-form health survey (SF 36), snore outcome survey
and a separate spouse/bed partner survey. They concluded
that by correcting an obstructed nasal airway they were
able to signiﬁcantly improve disease speciﬁc and generic
QoL thus, substantiating the role of nasal surgery in
treating these patients. However, in spite of the signiﬁcant
improvement noted in QoL parameters, disappointingly,
there was no statistically signiﬁcant improvement in the
objective polysomnographic data. This discrepancy
between objective and subjective results is shared by
numerous other similar studies following nasal surgery
alone for SRBD. Verse et al. [68] studied a cohort of 26
patients of whom 19 had OSA and 7 were simple snorers.
A variety of nasal surgical procedures including septorhi-
noplasty, septoplasty, sinus surgery and nasal valve surgery
were carried out. They concluded that although nasal sur-
gery signiﬁcantly improved sleep quality and daytime
somnolence, the surgical response rate in the apnoeic group
was in the region of 15% based on objective parameters
(AHI). Four of their patients had worsening of OSA in spite
of improving arousal index in some of these. This para-
doxical effect can be explained by the so-called ‘‘ﬁrst night
effect’’ (when the patient has the initial, preoperative, sleep
study for the ﬁrst time, he does not sleep well and as a
result the study it may not reﬂect the true severity of the
SRBD; but with the subsequent postoperative sleep study
the patient is already accustomed to the attachment of
various leads and hence, the recording on this occasion
reﬂects more accurately the severity of the problem).
Morinaga et al. [69] assessed the way in which pha-
ryngeal morphology affected the outcome of nasal surgery
in patients with OSA and nasal obstruction. The pharyngeal
morphological features they looked at included tonsil size,
Mallampati score, narrowness of fauces and the retroglos-
sal dimension. They concluded that a favourable surgical
outcome was seen in individuals who had a high-positioned
soft palate and/or in those with a wide retroglossal space.
Unlike Li et al. [66] they did not feel that the tonsil size
affected the outcome of nasal surgery. However, the most
important, and only randomised control trial was per-
formed by the group of Koutsourelakis in Athens in 2007
[70], who assigned 49 patients with OSA and deviated
nasal septum to either septoplasty or sham surgery and
found that despite improvements in nasal patency as
measured subjectively and objectively, there was no
change in AHI or daytime sleepiness as assessed by Ep-
worth Sleepiness Scale. Interestingly, in the surgical group
there were 4 (14.8%) responders (using Sher’s criteria of
reduction of AHI by more than 50%), however, only one
patient was disease-free (AHI\5). In conclusion, nasal
surgery may improve QoL and snoring in a subgroup of
patients with mild SDB and septal deviation. Although
nasal surgery is certainly not an effective general treatment
1370 Eur Arch Otorhinolaryngol (2011) 268:1365–1373
123for OSA, further studies may better deﬁne carefully
selected subgroups in which it may be of beneﬁt.
As adjunctive to CPAP
The second group of patients that may be considered for
nasal surgery are those who have failed CPAP therapy.
The treatment of choice for moderate or severe OSA is
CPAP but unfortunately it is frequently poorly tolerated
with compliance rates less than 70% [71]. One of the
reasons that patients may ﬁnd CPAP so uncomfortable is
either pre-existing structural nasal obstruction or CPAP-
induced rhinitis. More than 50% of CPAP users complain
of signiﬁcant nasal symptoms, including nasal congestion,
rhinorrhea, nasal dryness and sneezing [72]. Thus, it is
vital that patients who do not comply with or adhere
poorly to CPAP therapy should undergo detailed evalua-
tion of their upper airway to identify obstructive pathol-
ogy that may be surgically correctable. This may lead to a
reduction in the CPAP pressure and, therefore, improve
the compliance of this form of therapy. Powell [73]
demonstrated this in a group of CPAP patients undergoing
radiofrequency turbinate reduction. Patients in this study
reported a subjective improvement in nasal obstruction
which in turn was linked to improved CPAP use. Simi-
larly, Friedman et al. [74] showed a signiﬁcant decrease
in CPAP titration levels following nasal surgery. In this
study, reduction of pressure requirement for CPAP ther-
apy was noted in patients with mild, moderate and severe
OSA. The mean reduction of CPAP titration level was
from 9.3 cmH2O preoperatively to 6.7 cmH2O postoper-
atively. This reduction in pressure would certainly help in
improving the CPAP compliance.
Conclusion
It is now well recognised that improving nasal resistance
medically, surgically or with the use of dilators can
improve sleep quality; however, signiﬁcant improvement
in objective sleep parameters remain to be proven.
Although there is no role for nasal surgery as single
treatment for OSA, it is quite useful in improving
symptoms in simple snorers and potentially useful as part
of multilevel surgery in many patients with SRBD. In
CPAP failures if upper airway evaluation demonstrates an
obstructive nasal passage then treating this certainly
improves CPAP compliance and adherence. In general,
patients who responds positively to medical treatment
or nasal dilators may be candidates for nasal surgi-
cal intervention, taking into account the limitations
described.
Key points
1. Mechanisms through which nasal obstruction can lead
or contribute to sleep apnoeas include the Starling
resistor model, shunting of airﬂow through an unstable
oral airway, blocking of the nasal respiratory reﬂex
and reduced NO production and delivery.
2. Patients with self-reported nocturnal nasal obstruction
are up to threefold more likely to snore and suffer from
daytime somnolence.
3. Nasal steroids have been proven to improve subjective
quality of sleep in patients with allergic rhinitis, but are
not an effective treatment for adults with OSA.
4. Surgery to improve nasal patency is not indicated as
primary treatment in patients with OSA, however, in
selected patients with simple snoring it may reduce
snoring and improve QoL.
5. In patients with OSA and nasal obstruction using
CPAP, nasal surgery may reduce pressure require-
ments and improve compliance.
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medium, provided the original author(s) and source are credited.
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